Ikarian Capital, LLC logo

Ikarian Capital, LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Ikarian Capital, LLC with $494.3M in long positions as of Q3 2025, 72% allocated to Healthcare, and 47% concentrated in top 10 positions.

Portfolio Value
$494.3M
Top 10 Concentration
47%
Top Sector
Healthcare (72%)
US Exposure
93%
Market Cap Focus
Mid Cap
Countries
10

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 71.90%HealthcareETF: 0.80%
Healthcare
71.90%
ETF
0.80%

Industry Breakdown

8 industries across all sectors

Biotechnology: 70.04%BiotechnologyMedical - Specialties: 0.94%ETF: 0.75%Medical - Diagnostics & Research: 0.50%Drug Manufacturers - Specialty & Generic: 0.35%Medical - Instruments & Supplies: 0.05%Medical - Care Facilities: 0.03%Medical - Devices: 0.03%
Biotechnology
Healthcare
70.04%
Medical - Specialties
Healthcare
0.94%
ETF
ETF
0.75%
Medical - Diagnostics & Research
Healthcare
0.50%
Drug Manufacturers - Specialty & Generic
Healthcare
0.35%
Medical - Instruments & Supplies
Healthcare
0.047%
Medical - Care Facilities
Healthcare
0.029%
Medical - Devices
Healthcare
0.028%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Large Cap ($10B - $200B): 5.90%Mid Cap ($2B - $10B): 31.51%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 28.65%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 10.90%Micro Cap ($50M - $300M)Nano Cap (< $50M): 2.66%N/A (ETF or Unknown): 20.39%N/A (ETF or Unknown)
Large Cap ($10B - $200B)
5.90%
Mid Cap ($2B - $10B)
31.51%
Small Cap ($300M - $2B)
28.65%
Micro Cap ($50M - $300M)
10.90%
Nano Cap (< $50M)
2.66%
N/A (ETF or Unknown)
20.39%

Portfolio Concentration

Top 10 Holdings %
46.57%
Top 20 Holdings %
65.19%
Top 50 Holdings %
89.17%
Top 100 Holdings %
99.68%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
93.16%
International
6.84%
Countries
10
Largest Int'l Market
Netherlands - 2.75%
United States of America
93.16% ($460.5M)
100 holdings
Netherlands
2.75% ($13.6M)
4 holdings
Ireland
2.07% ($10.3M)
1 holdings
Canada
0.76% ($3.7M)
4 holdings
Switzerland
0.63% ($3.1M)
1 holdings
Germany
0.28% ($1.4M)
2 holdings
Singapore
0.14% ($702.4K)
1 holdings
Denmark
0.11% ($554.1K)
1 holdings
Belgium
0.05% ($232.9K)
1 holdings
Israel
0.04% ($206.3K)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
1.9 quarters
Avg. Top 20
2.5 quarters
Avg. All Positions
4 quarters
Median Holding Period
3 quarters
Persistence Rate
39.66%
Persistent Holdings Weight
23.87%
Persistent Positions
46
Longest Held
Lyra Therapeutics, Inc. Common Stock logo
Lyra Therapeutics, Inc. Common StockLYRA - 20 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
1.57%
Avg. Position Weight
0.86%
Largest Position
GMAB
Genmab A/S ADSGMAB - 10.73%
Largest Ownership Stake
Tenax Therapeutics, Inc. logo
Tenax Therapeutics, Inc.TENX - 21.21%
Avg. Ownership Stake
1.13%
Ownership Stake >5%
3
Ownership Stake >1%
32

Historical (Since Q4 2019)

Avg. New Position
1.40%
Avg. Ownership Stake
0.98%
Largest Position
Avalo Therapeutics, Inc. Common Stock logo
Avalo Therapeutics, Inc. Common StockAVTX - 84.97% (Q4 2021)
Largest Ownership Stake
Achieve Life Sciences, Inc. logo
Achieve Life Sciences, Inc.ACHV - 38.70% (Q2 2020)

Portfolio Turnover

Current Quarter

Turnover Ratio
48.4%
Value Traded
$239.17M
Positions Added
23
Positions Exited
22

Historical (Since Q4 2019)

Avg. Turnover Ratio
50.8%
Avg. Positions Added
20
Avg. Positions Exited
23
Highest Turnover
412.6%
Q2 2022
Lowest Turnover
2.4%
Q4 2021

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.